Executive Vice President - Research and Development
Dr. Sean E. Harper serves as Executive Vice President Research and Development of Amgen Inc., since February 2012. Dr. Harper joined the Company in 2002 and has held leadership roles in early development, medical sciences and global regulatory and safety
Harper served as Senior Vice President, Global Development and Corporationrationrate Chief Medical Officer from March 2007 to February 2012. Prior to joining the Company, Dr. Harper worked for five years at Merck Research Laboratories.
Management Efficency
The company has return on total asset (ROA) of 7.37 % which means that it generated profit of $7.37 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 23.95 % meaning that it created $23.95 on every $100 dollars invested by stockholders.
The company currently holds 23.89 B in liabilities with Debt to Equity (D/E) ratio of 1.23 which is about average as compared to similar companies. Amgen Inc has Current Ratio of 5.47 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Amgen Inc., a biotechnology medicines company, engages in the discovery, development, manufacture, and marketing of human therapeutic solutions in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada. Amgen Inc [AMGN] is traded on NASDAQ in USA. It is located in Thousand Oaks, CA and employs 18,000 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
1.03%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Buenos-Aires
Mexico
Hong Kong
